The Indian pharmaceutical sector "was once notorious for making cheap knockoffs of Western medicines" to sell in developing countries, says the New York Times, but now it is a manufacturing center of drugs to sell worldwide. "What I see happening now is manufacturing and even packaging and even formulation are moving to India," says Jim Worrell, the chief executive of Pharma Services Network.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.